Marshall Wace North America L.P. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 308 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$33,245,000
-15.9%
359,481
-29.3%
0.14%
-15.0%
Q2 2021$39,516,000
+27.4%
508,304
+22.1%
0.17%
+29.5%
Q1 2021$31,016,000
+1836.1%
416,150
+4330.0%
0.13%
+1742.9%
Q4 2020$1,602,000
+24.2%
9,394
+16.7%
0.01%
-22.2%
Q2 2020$1,290,000
-82.4%
8,048
-85.9%
0.01%
-74.3%
Q4 2019$7,343,000
+3724.5%
56,904
+2139.4%
0.04%
+3400.0%
Q3 2019$192,000
-94.9%
2,541
-89.7%
0.00%
-95.7%
Q2 2019$3,763,000
-92.9%
24,767
-94.4%
0.02%
-87.8%
Q1 2019$53,078,000
+181.7%
445,320
+158.0%
0.19%
+3.3%
Q4 2018$18,839,000
-62.8%
172,622
-44.9%
0.18%
+4.6%
Q3 2018$50,630,000
+36.9%
313,478
+12.0%
0.17%
-16.7%
Q2 2018$36,989,000
+36.3%
279,841
-23.6%
0.21%
+53.7%
Q1 2018$27,134,000
+99.3%
366,233
+49.7%
0.14%
+81.3%
Q4 2017$13,616,000
-20.0%
244,721
-35.3%
0.08%
-30.6%
Q3 2017$17,026,000
+3692.0%
378,347
+2763.9%
0.11%
+3500.0%
Q2 2017$449,00013,2110.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 87,180$2,581,0003.60%
Perceptive Advisors 1,771,029$52,422,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 483,047$14,298,0002.80%
HealthCor Management, L.P. 1,550,000$45,880,0002.10%
Camber Capital Management LP 1,350,000$39,960,0001.62%
Tourbillon Capital Partners, L.P. 1,537,518$45,511,0001.17%
Elk Creek Partners, LLC 562,522$16,651,0001.02%
EMERALD ADVISERS, LLC 818,705$24,234,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 604,467$17,892,0000.82%
Carlson Capital, L.P. 1,845,702$54,633,0000.70%
View complete list of SAREPTA THERAPEUTICS INC shareholders